Keywords: roche, files, nda, gs4104, flu, treatment, hoffmann-la

Roche files NDA for GS4104 flu treatment

Article | 05 May 1999

Hoffmann-La Roche has filed for approval to market its orally-activeneuraminidase inhibitor GS4104, a potential treatment for influenza, in the USA. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Gilead Sciences

Giliad Sciences

Go to company listing

Related Drugs

Relenza

Zanamivir

Go to drug listing